Moody Aldrich Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
Moody Aldrich Partners's EXAS Position: Q2 2024 in Review
Moody Aldrich Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 6,059 shares — an estimated $418K sold.
Moody Aldrich Partners first reported a position in EXAS in Q1 2017 and held it in 8 quarters. The position peaked at $627K in Q4 2023. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.
- Moody Aldrich Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
- Moody Aldrich Partners sold 6,059 Exact Sciences shares in Q2 2024, an estimated $418K.
- Moody Aldrich Partners first reported a position in Exact Sciences in Q1 2017 and held it in 8 quarters.
- Moody Aldrich Partners's Exact Sciences position peaked at $627K in Q4 2023.
- 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.
Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.